US EditionAward for Lars Lannfelt, Pioneer of Alzheimer's Drug "Lecanemab"
Summary by DZNE
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Scientists from Sweden are awarded "Hartwig Piepenbrock DZNE Prize" Bonn/Osnabrück, Stockholm (Sweden), June 26, 2025. The "Hartwig Piepenbrock DZNE Prize", endowed with 60,000 euros, will be awarded this year to Swedish medical scientist Lars Lannfelt for his pioneering contributions to the understanding of Alzheimer's disease and the development of the drug "Lecanemab". This is used for the treatment of Alzheimer's, the most common dementia di…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
